Umeå company, AcureOmics AB has received four million in funding from the European Commission for a research project to develop techniques to prevent kidney transplant rejection. The BIOMARGIN project (BIOMArkers of Renal Graft INjuries in kidney allograft recipients) aims to provide more individualized treatments in order to improve patients’ quality of life by increasing long-term survival of the transplanted kidney.
Business Sweden, the Swedish trade and invest council are, in collaboration with partners, arranging the Israeli-Nordic LS Partnering on May 20-22, in conjunction with the annual Biomed Israel Innovation Conference in Tel Aviv. The Biomed Israel Innovation Conference approximately gathers 3000 participants, from over 45 countries.
Umeå based company Betagenon is starting phase I clinical studies with their energy metabolism regulating substance, O304.
Can we trust the outcome of a race? Is that particular athlete really that good? Or does he or she simply have a skilled doping team behind the scene? Questions which jump in front of the mind of both co-competitors, spectators and journalists at The New York Magazine. Questions that Christer Malm and his team are now able to answer, thanks to their test that can detect blood doping with 100 % accuracy .
Don't miss the chance to get help from Umeå University’s absolutely sharpest and most ambitious students, who are capable of executing high quality assignments as consultants for your company.
Tillväxtverket support small and medium sized companies, who wants to and are capable of growing, and companies developing and refining competitive ideas.
There is a lot at stake, the competition, for say an Olympic gold, is fierce and for some the temptation to cheat is too great.
An intelligent rollator, a wheeled walker, that is what the researchers behind a project at Umeå University and Norrlands University hospital have in mind. The aim is to reduce tripping and falling accidents by inventing a rollator which can turn away from obstacles and prevent people from accidentally going down the curb.
On January 30, Biotech Umeå Investment Day took place at Grand Hôtel in Stockholm. The day started with partnering sessions between companies from the Umeå region and investors and business angels from Scandinavia and abroad – in total, over 60 partnering meetings took place during three hours.
BioTrinity is the premier European Biopartnering and Investment Conference within the life science/Biotech sector, with plenty of for partnering opportunities with R&D companies within big pharma and with more biomedical investors than any other European partnering conference in this field.
The organizers expect approximately 1000 visitors, including nearly 80 investors and 30 major pharmaceutical companies.
Research can save and improve people’s lives, and research institutions and companies are full of fantastic people with fabulous ideas. Ideas which could make life better, healthier, safer or simply just more interesting. But many ideas are stuck in the desk drawer.
Juridik för internationella affärer
Lunch seminar- How to succeed in partnering (seminar in Swedish)
Biotech Umeå, Uminova Innovation
Box 7978, SE-907 19 Umeå